AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SPIRULINA

9 registrations across 3 African markets— 8 active

Markets with SPIRULINA

Recent registrations

Brand / ProductMarketHolderStatusExpires
SNP-SPIRULINA
CAPSULE
🇿🇼ZimbabweADVENTURA INVESTMENTS LIMITEDactiveDec 2027
SPIRULINA PLATENSIS
TABLET; ORAL
🇿🇼ZimbabweSUNONY HERBAL DISTRIBUTORS PVT LTDactiveDec 2027
SPIRULINA
TABLET; ORAL
🇿🇼ZimbabweKANAGE HERBAL SOLUTIONactiveDec 2027
SPIRULINA
TABLET; ORAL
🇿🇼ZimbabweDYNAPHARM DNG ENTERPRISES PVT LTDactiveDec 2027
TIANSHI SPIRULINA
CAPSULE
🇿🇼ZimbabweTIENS INTERNATIONAL ZIMBABWEactiveDec 2027
SPIRULINA 0.25G CAPSULE
CAPSULE
🇲🇼MalawiexpiredJun 2013
DI SPIRULINA TABLET
Chewable Tablet
🇰🇪KenyaDYNAPHARM (M) SDN BHDactive
Spirulina Capsules
Capsule
🇰🇪KenyaTiwani Limitedactive
Spirulina
Capsule
🇰🇪KenyaX-Centric Limitedactive

SPIRULINA in Africa — Regulatory Overview

SPIRULINA is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Kenya, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.